Organ Donor Infectious Disease Testing Education

Slides:



Advertisements
Similar presentations
Simple as Home Healthcare Laboratory of America.
Advertisements

High Throughput Donor Plasma NAT Screening Assay Applied to Acute HIV Detection in a Public Health Setting December 5, 2007 Josh Goldsmith, Ph.D. National.
Ebola Virus Disease (EVD) Laboratory Diagnostics 04/12/2014.
Susan N. Hocevar, MD Medical Officer Office of Blood, Organ, and Other Tissue Safety Division of Healthcare Quality and Promotion Investigation Framework.
Is Nucleic Acid Testing for Organ Donors the ‘Right’ Choice? Reference: Humara A, Morrisb M, Blumbergc R, et al. Nucleic acid testing (NAT) of organ donors:
Align OPTN Policies with the 2013 PHS Guideline for Reducing Transmission of HIV, HBV, and HCV Through Solid Organ Transplantation (Resolution 13) Ad Hoc.
Ad Hoc Disease Transmission Advisory Committee Spring 2015.
F. Kourgia, M. Vini, E. Zervou
Umbilical Cord Blood Dubai Cord Blood Bank DCBB. CHAPTER I Background of Cord Blood.
The Recipient Experience Jaime Myers, RN, MSN, CCTC April 29, 2011.
OnSite HAV IgM Rapid Test Upgraded to Revision H for Better Sensitivity CTK-MK-PPT-R0090 Rev 1.0.
R Diagnostics June 19, 2003 WNV FDA BPAC MeetingPCR NAT Blood Screening TaqScreen West Nile Virus Program - Roche Update James L. Gallarda, Ph.D. Roche.
Top 5 OPTN Policy Violations
BioLife Plasma Services Experience with HBV NAT Testing
WP5 : omics Coordinators : Pr Marion Leboyer (France) Pr Dan Rujescu (Germany)
Organ Donor Infectious Disease Testing Education UW Health OPO July 2009.
Reentry for Donors Deferred Based on Anti-HBc Test Results November 3, 2005 BPAC Meeting FDA/CBER/OBRR/DETTD.
PHS GUIDELINE FOR REDUCING TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS, HEPATITIS B VIRUS AND HEPATITIS C VIRUS THROUGH SOLID ORGAN TRANSPLANTATION ACOT.
World Hepatitis Day 2013, 29 th July Establishing a framework for better data collection and surveillance of Hepatitis in South Africa N. Prabdial-Sing.
CE MARKING OF IVDDs - the NIBSC perspective Morag Ferguson Division of Virology.
Transfusion Therapy Principles of IV Therapy BSN336.
Update on Assay Development George J. Dawson, Ph.D. Infectious Diseases: Core R & D Abbott Laboratories West Nile Virus.
Revision Process for the PHS Guideline for Reducing HIV, HBV and HCV Transmission through Solid Organ Transplantation Matthew J. Kuehnert, M.D. Office.
10/14/2015 Office of Laboratory Services (OLS) th Avenue South Charleston WV
Review of Site Visit Report Laboratory of Molecular Virology DETTD/OBRR/CBER March 18, 2005 Hira L. Nakhasi, Ph.D. Director, DETTD.
CBER Source Plasma Labeling Judy Ellen Ciaraldi BS, MT(ASCP)SBB, CQA(ASQ) CBER, OBRR, DBA September 16, 2009.
Different Methods of Blood Sample Collection
Ad Hoc Disease Transmission Advisory Committee Fall 2014.
Epidemiology of Transfusion Transmitted Disease Sharyn Orton, MT(ASCP)SBB, M.S.P.H, Ph.D. candidate Project Leader, Transmissible Diseases Department American.
CBER Update on status of West Nile virus test, lot release and validation panel development Indira Hewlett, Ph.D CBER/FDA Blood Products Advisory Committee.
Update for nurses and phlebotomists taking blood samples for Transfusion in General Practice The Hospital Transfusion Team
BioPlex 2200 HIV Ag-Ab Assay
HLA - Tissue Typing Laboratory HLA - Tissue Typing Laboratory Department of Pathology & Laboratory Medicine Human Leukocyte Antigen (HLA) complex allows.
MICROBIOLOGY IRS. Gastroenteritis 1) Major cause of infantile death 2) Feacal-oral transmission 3) Gastroenteritis cause dehydration 4) 50 % of all causes.
1 Infectious Disease Verification to Enhance Patient Safety Operations and Safety Committee.
VIRAL DISEASES OF LIVER DR.JEYAKUMAR NELSON UNIT OF MICROBIOLOGY MBBS -BATCH 17.
Donations After Reentry
In The Name of God.
Table 3 Titers of antibody to hepatitis B surface antigen (anti-HBs) 2–4 weeks after the first vaccination From: Response to Hepatitis B Vaccine in HIV-1–Positive.
TRANSFUSION: Blood donation and preparation of blood components
An integral part of the healthcare experience
The Recipient Experience
UW Hospital and Clinics Organ Procurement Organization (OPO)
Expanding the Donation Opportunity:
Biomarker Screening Pilot
Laboratory Diagnosis of Infectious Diseases
RTA in Brief 1996 – Founded, started distribution of Merial poultry vaccines – Made investments in R&D activities for human health – Moved.
Mohamed Ali Daw, MD, PhD, FTCDI,MPS
Congratulations On having the opportunity to take the holy journey Before Hajj Do not forget to check your health GET UP TO 15% OFF Visit our Clinical.
HEPATITIS C AGA KHAN UNIVERSITY HOSPITAL. Hepatitis Screening Package.
Case Definition: HEPATITIS C
Clarify Informed Consent of Transmittable Conditions
R. Cavallo  Clinical Microbiology and Infection 
Clarify Informed Consent of Transmittable Conditions
The Organ Donation Process
Hepatitis Primary Care: Clinics in Office Practice
INTEGRATING HIV AND HCV TESTING.
پیشگیری از عفونتهای منتقله از راه خون
Combining rapid diagnostic tests and dried blood spot assays for point-of-care testing of human immunodeficiency virus, hepatitis B and hepatitis C infections.
Infectious causes of cancer: an evolving educational saga
The Organ Donation Process
NUCLEIC ACID AMPLIFICATION TESTING DETECTS HIV TRANSMISSION RISK IN SEROLOGICALLY- TESTED BLOOD DONOR UNITS. |Presented by Miss Shemau Muniru| Authors:
Transfusion Medicine Kristine Krafts, M.D..
Efficacy of Serologic Marker Screening in Identifying Hepatitis B Virus Infection in Organ, Tissue, and Cell Donors  Dominique Challine, Stéphane Chevaliez,
Clinical Microbiology and Infection
Liver is liver and blood is blood, and finally the twain have met
Clarify Informed Consent of Transmittable Conditions
A CASE SERIES OF DISCORDANT LABORATORY RESULTS WITH RAPID HIV TESTING
HIV Update, The OPO’s Perspective
COLLECT PATIENT BLOOD SAMPLE • Draw one (1) SST tube (Serum Separator Tube) from each patient using standard venipuncture technique • Allow blood to clot.
Presentation transcript:

Organ Donor Infectious Disease Testing Education UW Health OPO July 2009

UW health OPO performs the following infectious disease testing in compliance with the United Network for Organ Sharing (UNOS) standards for every donor: HIV I/II HTLV I/II Anti-HBc (Hepatitis B Core) HBsAg (Hepatitis B surface antigen) HCV (Hepatitis C) VDRL/RPR (Syphilis) CMV (Cytomegalovirus) EBV (Epstein-Barr Virus)

Current Challenges Early 2008 – Abbott labs discontinued FDA approved kit used by UWHC for Hepatitis B, Hepatitis C & HIV UW Health OPO given exemption by UNOS to perform diagnostic testing, Centaur

Current Status Donor serological testing is generally done at UW via diagnostic method. Only exception is in the case of a potential islet donor. These panels are sent to BCW (BloodCenter of Wisconsin) for FDA approved serologies. July 1, 2009 – All donor serological testing will be done at BCW, including NAT and WNV. The only blood testing done at UW will be ABO verification, EBV (send out) and HLA.

BloodCenter of Wisconsin Open since 1947 and located in Milwaukee, WI On call staff enables donor testing 24 hrs a day 365 days a year Approved for NAT testing on all donors

NAT Testing The industry standard is changing with regard to infectious disease testing. NAT (Nucleic Acid Testing) detects the genetic sequence of the virus, bacterium or parasite that is present in the host as a result of the infection. It is used for HIV, HCV, HBV and West Nile Virus. NAT shortens the window of detection for HIV & HCV from approximately 22 days to 5 days and for HBV and WNV to 1 day. Currently 45 out of the 58 OPOs are performing NAT.

New Process Initial donor blood draw will now need to be shipped in 2 packages Package 1—sent to BloodCenter of WI 3 7 ml EDTA (lavender) tubes 2 10 ml serum sample (red top—NOT serum separator) tubes Package 2—sent to UW 4 10 ml ACD (yellow top) tubes 1 5 or 7 ml lavender tubes

New Process For each bag Affix a label including patient’s first and last name, date of birth, date and time of draw and initials of person drawing Place the tubes in a biohazard bag and then package in a small box or envelope Write: To BloodCenter of WI on package 1 To UW Hospital ER on package 2

New Process Take samples to your ER triage A courier will be arranged to transport the samples from your ER to their destination Please call organ procurement coordinator on call with any questions: 608-262-2122

New Timeline Once blood arrives to BCW serology testing takes 4-6 hrs to complete; if any results are positive the test needs to be re-run and take an additional 4-6 hrs Once blood arrives to UW ER ABO takes under an hour EBV needs to be sent out and results arrive in 5 to 7 days HLA (tissue typing) takes about 4 hours

Thanks for your assistance!!